What is Cytarabine?

Category: Prescription Drugs

Most popular types: Ara-C Cylocide Cytosar-U Show all


See also: CALGB 9251 CODOX-M/IVAC Cytarabine-Daunorubicin Cytarabine-Doxorubicin Cytarabine-Idarubicin

Cytarabine (Cytosar-U, Ara-C) is an antimetabolite used in the treatment of acute myeloid leukemia, acute lymphocytic leukemia, blast phase of chronic myelocytic leukemia, and lymphomas; also for prophylaxis and treatment of meningeal leukemia.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Acute myeloid leukemia 26 1
Acute lymphocytic leukemia 24 0
Diffuse large B-cell lymphoma 2 1
Acute promyelocytic leukemia 1 3
Bone marrow transplant 1 1
Follicular lymphoma 1 1

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 1
Moderate 4
Mild 0
None 0

Commonly reported side effects and conditions associated with Cytarabine

Side effect Patients Percentage
Nausea 2
Fever 1
Hearing problems 1
Rashes (redness, swelling) 1
Spinning dizziness (vertigo) 1

Why patients stopped taking Cytarabine

Multiple reasons could be selected

Reason Patients Percentage
Course of treatment ended 3
Did not seem to work 1
See all 4 patients who've stopped taking Cytarabine


Stopped taking Cytarabine

Duration Patients Percentage
Less than 1 month 3
1 - 6 months 1
Adherence Evaluations Percentage
Always 2
Usually 3
Sometimes 0
Never taken as prescribed 0
Burden Evaluations Percentage
Very hard to take 2
Somewhat hard to take 3
A little hard to take 0
Not at all hard to take 0

What people switch to and from

Patients stopped taking Cytarabine and switched to:

Treatment Patients Percentage
Decitabine (Dacogen) 1
Last updated:
There are no evaluations for Cytarabine.